Tovorafenib (DAY101) or in Combination With Pimasertib for Participants With Melanoma and Other Solid Tumors
Day One Biopharmaceuticals, Inc.
Day One Biopharmaceuticals, Inc.
Quadriga Biosciences, Inc.
Case Comprehensive Cancer Center
Tocagen Inc.
National Cancer Institute (NCI)
Children's Oncology Group
Children's Oncology Group
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Novartis
Duke University
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Case Comprehensive Cancer Center